Suspected Pseudobulbar Affect in Neurodegenerative Disease

被引:1
|
作者
O'Connor, Maureen K. [1 ,2 ,3 ,4 ]
Frank, Brandon [3 ,4 ,5 ]
Decaro, Renee [5 ]
Vives-Rodriguez, Ana [5 ]
Hurley, Landon [5 ]
Turk, Katherine W. [3 ,4 ,5 ]
Budson, Andrew E. [3 ,4 ,5 ]
机构
[1] Bedford VA Healthcare Syst, Neuropsychol Serv, Bedford, MA 01730 USA
[2] Bedford VA Healthcare Syst, Geriatr Res Educ & Clin Ctr, Bedford, MA 01730 USA
[3] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA
[4] Boston Univ, Alzheimers Dis Res Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA
[5] VA Boston Healthcare Syst, Ctr Translat Cognit Neurosci, Boston, MA USA
关键词
Alzheimer's disease; dementia; pseudobulbar affect; NEUROPSYCHIATRIC SYMPTOMS; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; AFFECT PREVALENCE; MODEL SELECTION; DEMENTIA; ASSOCIATION; DEXTROMETHORPHAN/QUINIDINE; PATHOPHYSIOLOGY; EPIDEMIOLOGY;
D O I
10.1002/gps.70002
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To investigate the association between suspected pseudobulbar affect (PBA), clinical diagnosis, cognitive testing, and self-reported mood in older adults presenting for evaluation of dementia. Participants: Patients presenting to an outpatient memory disorders clinic (N = 311). Methods: We used traditional and novel network modeling approaches to examine associations between neuropsychological (NP) tests, patient and clinician rating scales, and the Center for Neurological Study-Lability Scale (CNS-LS) among patients with suspected AD (n = 133) and other neurocognitive diagnosis (n = 178). We then examined differences in test performance between patients with and without suspected PBA (CNS-LS cut-off of >= 13), while accounting for demographic and psychiatric covariates with propensity score matching. Group differences were assessed with Bayesian models. Results: Prevalence of suspected PBA in AD was slightly less than half (44.4%) and at a similar rate in other dementias (e.g., 46.9% in CVD and 45.5% in LBD). In network models, the CNS-LS was associated with higher anxiety and better word list recall. After accounting for covariates, AD patients with suspected PBA performed better on word list recall beta M = 0.40, 95% CI [0.15, 0.66], and committed fewer false positive errors on recognition beta M = -1.51, 95% CI [-2.34, -0.59] than AD patients without suspected PBA. There were no differences in patients with any other diagnostic impression, nor group differences on other NP measures. Conclusions: Patients with suspected PBA and AD diagnosis had better memory recall and recognition than those without suspected PBA, suggesting that impaired emotional regulation may be an early sign of AD in patients with less prominent memory decline. Better understanding PBA in neurodegenerative diseases, including prevalence and comorbidity with psychiatric conditions, could help with early identification, education, and initiation of treatment.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Pseudobulbar affect in neurodegenerative diseases: A systematic review and meta-analysis
    Nabizadeh, Fardin
    Nikfarjam, Mahsa
    Azami, Mobin
    Sharifkazemi, Hossein
    Sodeifian, Fatemeh
    JOURNAL OF CLINICAL NEUROSCIENCE, 2022, 100 : 100 - 107
  • [2] Memantine may affect pseudobulbar affect in patients with Alzheimer's disease
    Prokselj, Tatjana
    Jerin, Ales
    Kogoj, Ales
    ACTA NEUROPSYCHIATRICA, 2013, 25 (06): : 361 - 366
  • [3] The neuroanatomy of pseudobulbar affect
    Ghaffar, Omar
    Chamelian, Laurie
    Feinstein, Anthony
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2007, 19 (02) : 219 - 219
  • [4] Pseudobulbar Affect An Overview
    Goldin, Deana Shevit
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2020, 58 (09) : 19 - 24
  • [5] Treatment of pseudobulbar affect in a mixed neurodegenerative disorder with compounded quinidine capsules and dextromethorphan cough syrup
    Villeneuve, Yannick
    Cruz-Santiago, Diana
    Masson, Helene
    Clerc, Doris
    SAGE OPEN MEDICAL CASE REPORTS, 2020, 8
  • [6] Pseudobulbar Affect in Multiple Sclerosis
    Tamas, Olivera
    Bresliev, Aleksandar
    Valcic, Vanja
    Kovacevic, Marija
    Veselinovic, Nikola
    Budimkic, Maja
    Jovicevic, Vanja
    Momcilovic, Nikola
    Andabaka, Marko
    Vitkovic, Jelena
    Mesaros, Sarlota
    Drulovic, Jelena
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 746 - 746
  • [7] Recognizing and treating pseudobulbar affect
    Sauve, William M.
    CNS SPECTRUMS, 2016, 21 : 34 - 44
  • [8] Treatment of pseudobulbar affect in ALS
    Smith, RA
    Brooks, BR
    LANCET NEUROLOGY, 2005, 4 (05): : 270 - 270
  • [9] Pseudobulbar Affect or Depression in Dementia?
    Chang, Young D.
    Davis, Mellar P.
    Smith, Joshua
    Gutgsell, Terrence
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2016, 51 (05) : 954 - 958
  • [10] Dextromethorphan/QuinidineIn Pseudobulbar Affect
    Karly P. Garnock-Jones
    CNS Drugs, 2011, 25 : 435 - 445